Actively Recruiting
Efficacy of ERCP in the Diagnosis and Treatment of Idiopathic Recurrent Acute Pancreatitis
Led by Changhai Hospital · Updated on 2024-07-12
158
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
Sponsors
C
Changhai Hospital
Lead Sponsor
P
Peking Union Medical College Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if endoscopic retrograde cholangiopancreatography (ERCP) works to treat idiopathic recurrent pancreatitis (IRAP) in adults. It also clarify the efficacy of ERCP in the diagnosis of IRAP. The main questions it aims to answer are: Does ERCP reduce the frequency of pancreatitis episodes in IRAP patients? Does ERCP contribute to identify the etiology of IRAP patients? Participants will be randomly allocated to receive ERCP (pancreatic sphincterotomy and pancreatic stent placement) or conservative treatment and be followed for 1 year.
CONDITIONS
Official Title
Efficacy of ERCP in the Diagnosis and Treatment of Idiopathic Recurrent Acute Pancreatitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 to 70 years
- Diagnosed with idiopathic recurrent acute pancreatitis (IRAP) having 2 or more distinct acute pancreatitis episodes with full recovery between episodes
- No irreversible structural or functional pancreatic changes
- Cause of recurrent acute pancreatitis remains unknown after routine clinical investigations (history, labs, imaging)
- Experienced at least 1 acute pancreatitis episode within one year prior to enrollment
- Provided informed consent to participate in the study
You will not qualify if you...
- Prior sphincter intervention
- Not recovered from a previous acute pancreatitis attack
- Prior pancreatic surgery
- Contraindications to ERCP procedure
- Major mental illness or serious health problems unsuitable for study participation
- Pregnant or planning pregnancy within 12 months of enrollment
- Other conditions deemed inappropriate for study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Changhai Hospital
Shanghai, Shanghai Municipality, China, 200433
Actively Recruiting
Research Team
L
Lianghao Hu, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here